Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
# | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
---|---|---|---|---|---|---|
3451 | M1.ON.17.4751 | 108802 |
Oncology
|
Bladder Cancer |
M 2
|
C
|
3452 | M1.OMB.4752 | 214445 |
Oncology
|
Bladder Cancer |
M 2
|
A
|
3453 | M1.OMB.19.1 | 212829 |
Oncology
|
Bladder Cancer |
M 2
|
A
|
3454 | M1.OMB.19.1 | 212697 |
Oncology
|
Cancer Drugs Overview |
M 1
|
B
|
3455 | M1.OMB.18.4799 | 210502 |
Oncology
|
Cervical Cancer |
M 2
|
B
|
3456 | M1.ON.17.4798 | 109262 |
Oncology
|
Cervical Cancer |
M 2
|
D
|
3457 | M1.ON.17.4754 | 108965 |
Oncology
|
Chemical Carcinogens |
M 2
|
D
|
3458 | M1.ON.17.4868 | 109806 |
Oncology
|
Cholangiocarcinoma |
M 1
|
C
|
3459 | M1.OMB.19.4869 | 213586 |
Oncology
|
Cholangiocarcinoma |
M 2
|
B
|
3460 | M1.OMB.18.4699 | 210041 |
Oncology
|
Choriocarcinoma |
N/A
|
B
|
3461 | M1.OMB.18.4700 | 210841 |
Oncology
|
Choriocarcinoma |
M 2
|
B
|
3462 | M1.OMB.19.4698 | 213462 |
Oncology
|
Chronic Lymphocytic Leukemia (CLL) |
M 2
|
A
|
3463 | M1.OMB.18.4754 | 212512 |
Oncology
|
Chronic Myeloid Leukemia (CML) |
M 2
|
B
|
3464 | M1.ON.17.4753 | 108771 |
Oncology
|
Chronic Myeloid Leukemia (CML) |
M 3
|
D
|
3465 | M1.ON.17.4753 | 108854 |
Oncology
|
Colorectal Cancer (CRC) |
M 1
|
C
|
3466 | M1.ON.15.4666 | 107112 |
Oncology
|
Colorectal Cancer (CRC) |
M 1
|
E
|
3467 | M1.ON.13.60 | 101117 |
Oncology
|
Colorectal Cancer (CRC) |
M 4
|
E
|
3468 | M1.OMB.18.4754 | 210510 |
Oncology
|
Colorectal Cancer (CRC) |
M 2
|
B
|
3469 | M1.OMB.19.1 | 213363 |
Oncology
|
Colorectal Cancer (CRC) |
M 2
|
B
|
3470 | M1.OMB.18.1 | 210688 |
Oncology
|
Endometrial Carcinoma |
M 4
|
B
|
3471 | M1.OMB.1 | 214370 |
Oncology
|
Endometrial Carcinoma |
M 2
|
A
|
3472 | M1.ON.13.31 | 101088 |
Oncology
|
Esophageal Cancer |
M 2
|
E
|
3473 | M1.ON.14.6 | 101063 |
Oncology
|
Esophageal Cancer |
M 2
|
D
|
3474 | M1.ON.17.4798 | 109235 |
Oncology
|
Esophageal Cancer |
M 2
|
D
|
3475 | M1.OMB.20.1 | 214259 |
Oncology
|
Essential Thrombocytosis |
M 2
|
A
|
3476 | M1.ON.18.4872 | 109897 |
Oncology
|
Gallbladder Adenocarcinoma |
M 2
|
B
|
3477 | M1.OMB.19.4799 | 213534 |
Oncology
|
Gastric Cancer |
N/A
|
B
|
3478 | M1.ON.17.4798 | 109236 |
Oncology
|
Gastric Cancer |
M 2
|
C
|
3479 | M1.ON.13.9 | 101066 |
Oncology
|
Gastric Cancer |
M 4
|
E
|
3480 | M1.ON.13.83 | 101140 |
Oncology
|
Gastric Cancer |
M 2
|
E
|
3481 | M1.ON.14.23 | 104663 |
Oncology
|
Hairy Cell Leukemia (HCL) |
M 2
|
E
|
3482 | M1.ON.17.4867 | 109646 |
Oncology
|
Hairy Cell Leukemia (HCL) |
M 2
|
D
|
3483 | M1.OMB.19.4700 | 213439 |
Oncology
|
Hepatic Adenoma |
M 2
|
B
|
3484 | M1.OMB.19.4755 | 213179 |
Oncology
|
Hepatocellular Carcinoma (HCC) |
M 2
|
B
|
3485 | M1.ON.17.4707 | 108436 |
Oncology
|
Hepatocellular Carcinoma (HCC) |
M 1
|
C
|
3486 | M1.ON.17.4697 | 108130 |
Oncology
|
Hepatocellular Carcinoma (HCC) |
M 2
|
C
|
3487 | M1.ON.17.4754 | 108716 |
Oncology
|
Hepatocellular Carcinoma (HCC) |
M 2
|
C
|
3488 | M1.ON.17.4753 | 108772 |
Oncology
|
Hodgkin Lymphoma |
M 2
|
C
|
3489 | M1.ON.13.6 | 101316 |
Oncology
|
Hodgkin Lymphoma |
M 2
|
E
|
3490 | M1.OMB.18.1 | 210898 |
Oncology
|
Langerhans Cell Histiocytoses |
M 2
|
B
|
3491 | M1.OMB.18.4700 | 210524 |
Oncology
|
Langerhans Cell Histiocytoses |
M 2
|
B
|
3492 | M1.OMB.18.4754 | 212548 |
Oncology
|
Lung Cancer |
M 2
|
B
|
3493 | M1.OMB.18.1 | 210543 |
Oncology
|
Lung Cancer |
M 3
|
B
|
3494 | M1.OMB.18.1 | 210048 |
Oncology
|
Lung Cancer |
N/A
|
B
|
3495 | M1.OMB.19.4755 | 212785 |
Oncology
|
Lung Cancer |
M 2
|
A
|
3496 | M1.OMB.19.1 | 213772 |
Oncology
|
Lung Cancer |
M 2
|
A
|
3497 | M1.ON.13.36 | 100839 |
Oncology
|
Lung Cancer |
M 2
|
E
|
3498 | M1.ON.13.39 | 100842 |
Oncology
|
Lung Cancer |
M 2
|
D
|
3499 | M1.ON.13.68 | 100871 |
Oncology
|
Lung Cancer |
M 1
|
D
|
3500 | M1.ON.13.121 | 100924 |
Oncology
|
Lung Cancer |
M 3
|
E
|
3501 | M1.ON.14.105 | 100908 |
Oncology
|
Lung Cancer |
M 2
|
E
|
3502 | M1.OMB.1 | 214441 |
Oncology
|
Lung Cancer |
M 2
|
A
|
3503 | M1.ON.17.4753 | 108895 |
Oncology
|
Lung Cancer |
M 1
|
C
|
3504 | M1.ON.15.4666 | 107110 |
Oncology
|
Lung Cancer |
M 4
|
E
|
3505 | M1.ON.16.4697 | 108118 |
Oncology
|
Malignant Bone Tumors |
M 2
|
D
|
3506 | M1.ON.17.4723 | 108547 |
Oncology
|
Malignant Bone Tumors |
M 1
|
C
|
3507 | M1.OMB.4728 | 214332 |
Oncology
|
Malignant Bone Tumors |
M 2
|
A
|
3508 | M1.OMB.19.4726 | 212799 |
Oncology
|
Malignant Bone Tumors |
M 2
|
A
|
3509 | M1.OMB.19.4727 | 213773 |
Oncology
|
Malignant Bone Tumors |
M 2
|
A
|
3510 | M1.OMB.18.4724 | 210409 |
Oncology
|
Malignant Bone Tumors |
N/A
|
B
|
3511 | M1.OMB.18.4725 | 212441 |
Oncology
|
Malignant Bone Tumors |
M 2
|
B
|
3512 | M1.OMB.20.4874 | 213878 |
Oncology
|
Malignant Breast Tumors |
M 2
|
A
|
3513 | M1.ON.13.1 | 101662 |
Oncology
|
Malignant Breast Tumors |
M 2
|
D
|
3514 | M1.ON.17.4752 | 108767 |
Oncology
|
Malignant Breast Tumors |
M 1
|
C
|
3515 | M1.ON.17.4873 | 109976 |
Oncology
|
Malignant Breast Tumors |
M 2
|
C
|
3516 | M1.ON.15.4666 | 107111 |
Oncology
|
Malignant Breast Tumors |
M 2
|
C
|
3517 | M1.ON.13.1 | 101301 |
Oncology
|
Melanoma |
M 1
|
D
|
3518 | M1.ON.13.1 | 101307 |
Oncology
|
Melanoma |
M 4
|
E
|
3519 | M1.ON.14.19 | 103812 |
Oncology
|
Melanoma |
M 4
|
C
|
3520 | M1.ON.14.23 | 103816 |
Oncology
|
Melanoma |
M 1
|
D
|
3521 | M1.OMB.19.1 | 213644 |
Oncology
|
Melanoma |
M 2
|
A
|
3522 | M1.OMB.18.24 | 210811 |
Oncology
|
Melanoma |
N/A
|
B
|
3523 | M1.OMB.18.4723 | 210996 |
Oncology
|
Metastasis |
N/A
|
B
|
3524 | M1.OMB.18.1 | 210932 |
Oncology
|
Metastasis |
N/A
|
B
|
3525 | M1.ON.17.4722 | 108544 |
Oncology
|
Metastasis |
M 2
|
D
|
3526 | M1.ON.17.4752 | 108765 |
Oncology
|
Microtubule Inhibitors |
M 4
|
C
|
3527 | M1.ON.17.4697 | 108160 |
Oncology
|
Microtubule Inhibitors |
M 3
|
C
|
3528 | M1.OMB.18.1 | 212323 |
Oncology
|
Microtubule Inhibitors |
N/A
|
B
|
3529 | M1.OMB.19.4753 | 213650 |
Oncology
|
Microtubule Inhibitors |
M 3
|
B
|
3530 | M1.OMB.20.4756 | 214228 |
Oncology
|
Multiple Myeloma |
M 2
|
A
|
3531 | M1.OMB.18.4755 | 212334 |
Oncology
|
Multiple Myeloma |
N/A
|
B
|
3532 | M1.ON.17.4754 | 108696 |
Oncology
|
Multiple Myeloma |
M 2
|
C
|
3533 | M1.ON.15.27 | 105637 |
Oncology
|
Multiple Myeloma |
M 1
|
C
|
3534 | M1.ON.15.4671 | 107158 |
Oncology
|
Multiple Myeloma |
M 2
|
E
|
3535 | M1.ON.15.75 | 106765 |
Oncology
|
Multiple Myeloma |
M 1
|
B
|
3536 | M1.OMB.4757 | 215131 |
Oncology
|
Multiple Myeloma |
M 2
|
A
|
3537 | M1.ON.17.4799 | 109314 |
Oncology
|
Mycosis Fungoides / Sezary Syndrome |
M 1
|
D
|
3538 | M1.ON.17.4884 | 110009 |
Oncology
|
Myelofibrosis |
M 2
|
C
|
3539 | M1.OMB.1 | 214641 |
Oncology
|
Myelofibrosis |
M 2
|
A
|
3540 | M1.OMB.18.1 | 212486 |
Oncology
|
Myelofibrosis |
M 2
|
B
|
3541 | M1.ON.13.29 | 101339 |
Oncology
|
Non-Hodgkin Lymphoma |
M 1
|
E
|
3542 | M1.ON.13.147 | 101457 |
Oncology
|
Non-Hodgkin Lymphoma |
M 1
|
E
|
3543 | M1.ON.17.4717 | 108500 |
Oncology
|
Non-Hodgkin Lymphoma |
M 1
|
D
|
3544 | M1.ON.17.4695 | 107992 |
Oncology
|
Oncogenes |
M 1
|
B
|
3545 | M1.ON.17.4707 | 108448 |
Oncology
|
Oncogenes |
M 2
|
D
|
3546 | M1.ON.17.4747 | 108672 |
Oncology
|
Oncogenic Viruses |
M 1
|
D
|
3547 | M1.OMB.18.1 | 210804 |
Oncology
|
Oncogenic Viruses |
M 2
|
B
|
3548 | M1.ON.17.4799 | 109268 |
Oncology
|
Ovarian Tumors |
M 2
|
C
|
3549 | M1.ON.17.4752 | 108755 |
Oncology
|
Ovarian Tumors |
M 2
|
C
|
3550 | M1.ON.13.1 | 101235 |
Oncology
|
Ovarian Tumors |
M 2
|
E
|
3551 | M1.ON.13.1 | 100501 |
Oncology
|
Ovarian Tumors |
M 1
|
E
|
3552 | M1.ON.13.10 | 100510 |
Oncology
|
Ovarian Tumors |
M 2
|
E
|
3553 | M1.ON.13.10 | 100813 |
Oncology
|
Pancoast Tumor |
M 2
|
E
|
3554 | M1.ON.14.135 | 100938 |
Oncology
|
Pancoast Tumor |
M 2
|
E
|
3555 | M1.ON.16.75 | 106760 |
Oncology
|
Pancoast Tumor |
M 2
|
C
|
3556 | M1.OMB.19.136 | 213365 |
Oncology
|
Pancoast Tumor |
M 2
|
B
|
3557 | M1.OMB.18.1 | 210644 |
Oncology
|
Pancreatic Cancer |
M 2
|
B
|
3558 | M1.ON.13.66 | 101123 |
Oncology
|
Pancreatic Cancer |
M 2
|
E
|
3559 | M1.ON.16.4699 | 108390 |
Oncology
|
Parathyroid Adenoma |
M 1
|
C
|
3560 | M1.ON.17.4869 | 109748 |
Oncology
|
Parathyroid Adenoma |
M 1
|
D
|
3561 | M1.ON.14.53 | 106356 |
Oncology
|
Penis Cancer |
M 4
|
E
|
3562 | M1.ON.17.4697 | 108157 |
Oncology
|
Platinum Analogs |
M 3
|
C
|
3563 | M1.ON.17.4751 | 108789 |
Oncology
|
Platinum Analogs |
M 1
|
D
|
3564 | M1.ON.17.4798 | 109194 |
Oncology
|
Polycythemia Vera |
M 1
|
C
|
3565 | M1.ON.15.4666 | 107107 |
Oncology
|
Polycythemia Vera |
M 1
|
E
|
3566 | M1.ON.15.75 | 106754 |
Oncology
|
Polycythemia Vera |
M 1
|
D
|
3567 | M1.OMB.1 | 214885 |
Oncology
|
Polycythemia Vera |
M 2
|
A
|
3568 | M1.ON.15.75 | 106783 |
Oncology
|
Primary Brain Tumors |
M 2
|
E
|
3569 | M1.ON.16.4753 | 108896 |
Oncology
|
Primary Brain Tumors |
M 2
|
D
|
3570 | M1.ON.17.4868 | 109807 |
Oncology
|
Primary Brain Tumors |
M 1
|
C
|
3571 | M1.ON.17.4720 | 108513 |
Oncology
|
Primary Brain Tumors |
M 1
|
C
|
3572 | M1.ON.18.4872 | 109890 |
Oncology
|
Primary Brain Tumors |
M 2
|
B
|
3573 | M1.OMB.18.4873 | 210410 |
Oncology
|
Primary Brain Tumors |
N/A
|
B
|
3574 | M1.OMB.18.1 | 212324 |
Oncology
|
Primary Brain Tumors |
M 2
|
B
|
3575 | M1.OMB.18.1 | 210944 |
Oncology
|
Primary Brain Tumors |
M 2
|
B
|
3576 | M1.OMB.19.1 | 213600 |
Oncology
|
Primary Brain Tumors |
M 2
|
A
|
3577 | M1.OMB.20.4874 | 213726 |
Oncology
|
Primary Brain Tumors |
M 2
|
A
|
3578 | M1.OMB.20.1 | 214278 |
Oncology
|
Primary Brain Tumors |
M 2
|
A
|
3579 | M1.OMB.20.4801 | 214218 |
Oncology
|
Principles of Neoplasia |
M 1
|
A
|
3580 | M1.OMB.18.1 | 212314 |
Oncology
|
Principles of Neoplasia |
M 1
|
B
|
3581 | M1.ON.17.4754 | 108964 |
Oncology
|
Principles of Neoplasia |
M 1
|
C
|
3582 | M1.ON.17.4799 | 109310 |
Oncology
|
Principles of Neoplasia |
M 1
|
C
|
3583 | M1.ON.16.4699 | 108402 |
Oncology
|
Prostate Cancer |
M 2
|
D
|
3584 | M1.OMB.18.4700 | 210365 |
Oncology
|
Prostate Cancer |
N/A
|
B
|
3585 | M1.OMB.19.1 | 212791 |
Oncology
|
Prostate Cancer |
M 3
|
B
|
3586 | M1.OMB.19.1 | 213571 |
Oncology
|
Renal Cell Carcinoma |
M 2
|
B
|
3587 | M1.OMB.18.4873 | 210742 |
Oncology
|
Renal Cell Carcinoma |
M 4
|
B
|
3588 | M1.ON.18.4872 | 109915 |
Oncology
|
Renal Cell Carcinoma |
M 2
|
B
|
3589 | M1.ON.17.4756 | 108921 |
Oncology
|
Renal Cell Carcinoma |
M 1
|
C
|
3590 | M1.ON.13.87 | 101041 |
Oncology
|
Renal Cell Carcinoma |
M 1
|
E
|
3591 | M1.ON.17.4799 | 109323 |
Oncology
|
Salivary Gland Tumors |
M 1
|
D
|
3592 | M1.OMB.4701 | 214522 |
Oncology
|
Soft Tissue Tumors |
M 2
|
A
|
3593 | M1.OMB.19.4700 | 213445 |
Oncology
|
Soft Tissue Tumors |
M 2
|
A
|
3594 | M1.OMB.19.68 | 213186 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 2
|
A
|
3595 | M1.ON.13.1 | 101308 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 1
|
E
|
3596 | M1.ON.14.57 | 106379 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 2
|
C
|
3597 | M1.ON.14.10 | 103803 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 4
|
D
|
3598 | M1.ON.14.67 | 106140 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 2
|
E
|
3599 | M1.ON.14.26 | 103819 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 2
|
D
|
3600 | M1.ON.14.51 | 104262 |
Oncology
|
Squamous Cell Carcinoma (SCC) of the Skin |
M 2
|
B
|